The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of Death

NCT00568737 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2640

Enrollment

INDUSTRY

Sponsor class

Conditions

Sepsis

Interventions

DRUG: Drotrecogin alfa (activated)
DRUG: Placebo

Sponsor

Eli Lilly and Company